 CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL, WITH OR WITHOUT EPIRUBICIN HYDROCHLORIDE, IN TREATING WOMEN WHO HAVE UNDERGONE SURGERY FOR BREAST CANCER GROUP III CLOSED TO NEW PATIENTS AS OF 1272009: 